EdgarLookup
DEF 14A

DEF 14A Filing

Company
Arcturus Therapeutics Holdings Inc.
Filed
May 2, 2022
Period of Report
June 21, 2022
Accession Number
0001193805-22-000731

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →